Vaccinea | Pig no. | VNT titer versus O/Tibet/CHA/99b | Response to challenge with O/Tibet/CHA/99 | Vaccinea | Pig no. | VNT titer versus O/Tibet/CHA/99b | Response to challenge with O/Tibet/CHA/99 | ||
---|---|---|---|---|---|---|---|---|---|
Lesionsc | 3ABCd | Lesionsc | 3ABCd | ||||||
O/HN/CHA/93 | 101 | 1.6 | - | - | rM-HN | 601 | 2.1 | - | - |
102 | 1.7 | - | - | 202 | 1.6 | - | - | ||
103 | 2.0 | - | - | 203 | 1.6 | - | - | ||
104 | 1.7 | - | - | 204 | 2.0 | - | - | ||
105 | 1.5 | - | - | 205 | 1.8 | - | - | ||
106 | 2.1 | - | - | 206 | 2.1 | - | - | ||
107 | 1.8 | - | - | 207 | 1.7 | - | - | ||
108 | 2.0 | - | - | 208 | 1.9 | - | - | ||
109 | 1.5 | - | - | 209 | 1.8 | - | - | ||
110 | 1.9 | - | - | 210 | 2.0 | - | - | ||
111 | 2.1 | - | - | 211 | 1.8 | - | + | ||
112 | 1.9 | - | - | 212 | 2.0 | - | - | ||
113 | 1.8 | - | - | 213 | 1.6 | - | - | ||
114 | 1.6 | - | - | 214 | 2.1 | - | - | ||
115 | 2.1 | - | - | 215 | 1.7 | - | - | ||
116 | 1.7 | - | - | 216 | 2.0 | - | - | ||
Control | 117 | <1.0 | ++ | + | Control | 217 | <1.0 | ++ | + |
 | 118 | <1.0 | ++ | + |  | 218 | <1.0 | ++ | + |